References
- Takano S, Matsushita N, Oishi M, Okamoto S, Teranishi Y, Yokota C, et al. Site-specific analysis of B-cell non-Hodgkin's lymphomas of the head and neck: A retrospective 10-year observation. Acta Otolaryngol. 2015;135:1168-1171. https://doi.org/10.3109/00016489.2015.1061700
- Singh R, Shaik S, Negi BS, Rajguru JP, Patil PB, Parihar AS, et al. Non-Hodgkin's lymphoma: A review. J Family Med Prim Care. 2020;9:1834-1840. https://doi.org/10.4103/jfmpc.jfmpc_1037_19
- Storck K, Brandstetter M, Keller U, Knopf A. Clinical presentation and characteristics of lymphoma in the head and neck region. Head Face Med. 2019;15:1-8. https://doi.org/10.1186/s13005-018-0186-0
- Vega F, Lin P, Medeiros LJ. Extranodal lymphomas of the head and neck. Ann Diagn Pathol. 2005;9:340-350. https://doi.org/10.1016/j.anndiagpath.2005.09.020
- Han MW, Choi SH, Kim SY, Nam SY. Primary Non-Hodgkin's Lymphoma of the Larynx. Korean J Otorhinolaryngol-Head Neck Surg. 2009;52:762-766. https://doi.org/10.3342/kjorl-hns.2009.52.9.762
- Firat Y, Kizilay A, Sogutlu G, Mizrak B. Primary mucosa-associated lymphoid tissue lymphoma of hypopharynx. J Craniofac Surg. 2007;18:1189-1193. https://doi.org/10.1097/scs.0b013e31815783ab
- Bruzgielewicz A, Rojek D, Osuch-Wocikiewicz E, Niemczyk K. [Primary location of non-Hodgin's lymphoma (type MALT) in hypopharynx--case report]. Otolaryngol Pol. 2004;58:1005-1007.
- Tsang RW, Gospodarowicz MK, Pintilie M, Wells W, Hodgson DC, Sun A, et al. Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome. J Clin Oncol. 2003;21:4157-4164. https://doi.org/10.1200/JCO.2003.06.085
- Suh C, Huh J, Roh JL. Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue arising in the extracranial head and neck region: a high rate of dissemination and disease recurrence. Oral Oncol. 2008;44:949-955. https://doi.org/10.1016/j.oraloncology.2007.11.011
- Raderer M, Kiesewetter B, Ferreri AJ. Clinicopathologic characteristics and treatment of marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). CA Cancer J Clin. 2016;66:153-171. https://doi.org/10.3322/caac.21330
- Zullo A, Hassan C, Ridola L, Repici A, Manta R, Andriani A. Gastric MALT lymphoma: old and new insights. Ann Gastroenterol. 2014;27:27-33.
- Zucca E, Arcaini L, Buske C, Johnson PW, Ponzoni M, Raderer M, et al. Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020;31:17-29. https://doi.org/10.1016/j.annonc.2019.10.010
- Tanimoto K, Kaneko A, Suzuki S, Sekiguchi N, Maruyama D, Kim SW, et al. Long-term follow-up results of no initial therapy for ocular adnexal MALT lymphoma. Ann Oncol. 2006;17:135-140. https://doi.org/10.1093/annonc/mdj025
- Ejima Y, Sasaki R, Okamoto Y, Maruta T, Azumi A, Hayashi Y, et al. Ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiotherapy. Radiother Oncol. 2006;78:6-9. https://doi.org/10.1016/j.radonc.2005.11.005
- Zucca E, Conconi A, Laszlo D, Lopez-Guillermo A, Bouabdallah R, Coiffier B, et al. Addition of rituximab to chlorambucil produces superior event-free survival in the treatment of patients with extranodal marginal-zone B-cell lymphoma: 5-year analysis of the IELSG-19 Randomized Study. J Clin Oncol. 2013;31:565-572. https://doi.org/10.1200/JCO.2011.40.6272